Aims To compare management and clinical outcomes in hospitals stratified by the availability of on-site catheterization in InTIME-II, a multicentre trial comparing alteplase with lanoteplase for acute myocardial infarction.
Introduction
Although fibrinolytic therapy has proven to be a major advance in the treatment of patients with acute myocardial infarction [1] , current regimens are limited by the failure of initial reperfusion, inadequate myocardial tissue perfusion, residual coronary stenosis, recurrent ischaemia, and reocclusion in significant percentages of patients [2] [3] [4] [5] [6] [7] . As a result of these limitations, there has been a growing trend to use coronary angiography and revascularization in patients with ST-segment elevation acute myocardial infarction after fibrinolysis, with the hope of reducing the risk of adverse outcomes.
Routine use of coronary revascularization in STelevation acute myocardial infarction following fibrinolysis has not been shown to reduce the incidence of death or reinfarction in prior randomized studies [8] [9] [10] , yet there is evidence that selected patients may benefit from these procedures [11, 12] . Most guidelines for postinfarction management stress the importance of spontaneous or exercise-induced ischaemia and impaired ventricular function as criteria for the use of early angiography [13, 14] . In addition, performing coronary angiography after acute myocardial infarction may be useful in obtaining prognostic information as well as details of the coronary anatomy required for subsequent coronary revascularization [15] . Over the last decade, several studies have documented that the availability of on-site cardiac catheterization is a major determinant of the use of coronary angiography and revascularization after an acute myocardial infarction [16] [17] [18] [19] [20] [21] [22] [23] [24] . For example, in the conservative arm of the Thrombolysis In Myocardial Infarction (TIMI) IIB trial, patients enrolled in a hospital with on-site catheterization facility had a twofold increase in the likelihood of undergoing cardiac catheterization [16] . However, higher rates of use of cardiac procedures did not appear to result in improved survival.
Most previous studies comparing availability of onsite cardiac catheterization and outcomes have been carried out within a single country or region, and limited data exist for hospitals participating in a worldwide trial of acute myocardial infarction. In addition, prior studies were performed in an earlier era that pre-dated several important advances including better percutaneous catheters and devices (in particular intracoronary stents), improved antiplatelet therapies (thienopyridines, glycoprotein IIb/IIIa inhibitors), advances in coronary artery bypass surgery techniques, and wide distribution of evidence-based clinical practice guidelines. To evaluate the influence of availability of on-site catheterization on clinical outcomes and patterns of care in a contemporary international trial of fibrinolysis, we examined data from the InTIME (Intravenous nPA for Treatment of Infarcting Myocardium Early) II trial [25] . Since mortality may be affected by the rapid availability of coronary angiography and revascularization, we tested the hypothesis that patients admitted to hospitals with 24-h on-site facilities have better outcomes than patients admitted to hospitals with daytime facilities only, or to hospitals with no on-site facilities.
Methods

Study population
We studied the 15 078 patients enrolled in InTIME II, a phase III, randomized, double-blind, multicentre equivalence trial, designed to test whether single-bolus lanoteplase was at least as effective as accelerated alteplase [25] . Eligibility criteria included: age d18 years; onset of symptoms of acute myocardial infarction c6 h; ST-segment elevations d0·1 mV in two or more limb leads, or d0·2 mV in two or more contiguous precordial leads; or new or presumed new complete left bundlebranch block. Exclusion criteria on admission included pregnancy or lactation; increased risk of severe bleeding; any history of cerebrovascular accident, transient ischaemic attack or central nervous system structural damage; diabetic haemorrhagic retinopathy or other haemorrhagic ophthalmic conditions; systolic blood pressure d180 mmHg or diastolic blood pressure d110 mmHg; Killip class IV; symptoms suggestive of aortic dissection; concomitant use of oral anticoagulants; exposure to any investigational drug, treatment, or device within 30 days of presentation; and any medical condition that would render the subject unable to complete the study, interfere with optimal participation in the study, or result in significant risk to the subject.
After providing informed consent, patients were randomly assigned in a 2:1 ratio to receive 120 KU . kg 1 single-bolus lanoteplase, or an accelerated infusion of alteplase, administered as a bolus dose of 15 mg, followed by an infusion of 0·75 mg . kg 1 over a 30-min period (not to exceed 50 mg) and an infusion of 0·5 mg . kg 1 (up to 35 mg) over the next 60 min. Aspirin was given as soon as possible and then in a daily dose of 100-325 mg. With the assigned fibrinolytic therapy, patients also received a bolus dose of 70 U . kg 1 (maximum 4000 units) of heparin, followed by an infusion of 15 U . h 1 (maximum 1000 units). Except for treatment with fibrinolytic agents, aspirin, and heparin, the management of myocardial infarction (including the use of coronary angiography and revascularization) was left to the discretion of the treating physicians.
Characteristics of the hospitals
By means of a supplemental questionnaire, we surveyed all 855 hospitals from 35 countries participating in InTIME II regarding location, size, teaching status, type of physician specialty that usually cares for myocardial infarction patients after admission, and on-site facilities (cardiac catheterization, percutaneous coronary intervention, coronary artery bypass grafting (CABG) and computerized tomography scanning of the brain). Hospitals were stratified by the on-site availability of catheterization as 24 h, daytime only and no on-site facilities (Table 1) . A more detailed analysis of geographic variations in patient management and outcomes in InTIME-II is described in a separate paper [26] .
Characteristics of the patients
Data on demographic and clinical variables, procedures, and events were collected during the patient's stay in hospital, within 30 days, and at 6 months after myocardial infarction via the case-report forms. For the purposes of this analysis, all procedures and outcomes for a patient were attributed to the original admitting hospital, even if the procedure (e.g. coronary angiography) or outcome actually occurred after the patient had been transferred to another facility.
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Outcomes
The primary outcome was 30-day all-cause mortality. Secondary clinical outcomes included recurrent myocardial infarction (as adjudicated by the Clinical Events Committee), post-infarction angina, angina status graded according to the Canadian Cardiovascular Society Class (CCSC), and cardiogenic shock. Primary safety outcomes included stroke (as adjudicated by the Neurologic Event Committee) and major bleeding (intracranial haemorrhage, or bleeding requiring transfusion and resulting in haemodynamic compromise). Mechanical cardiac complications included acute mitral regurgitation, ventricular septal defect, and cardiac rupture.
Statistical analysis
The chi-square test for trend and the analysis-ofvariance for trend were used to identify differences between groups. To evaluate the influence of baseline characteristics on mortality, logistic models were constructed using both forward and backward stepwise procedures, which selected any baseline characteristic significantly associated (P<0·05) with 30-day mortality. The availability of coronary catheterization (trichotomized as 24 h, day only, or no availability) was forced into the model in the final step. Model results are presented as an odds ratio with 95% confidence intervals. A Cox regression model was used to analyse 1-year data. Mortality among the three groups of hospitals was also compared after stratification by the TIMI Risk Score for ST-elevation myocardial infarction [27] , a weighted scale of independent predictors of 30-day mortality.
To evaluate the influence of on-site facilities on the likelihood of undergoing angiography, logistic models were constructed that included variables shown to be significantly associated (P<0·05) with angiography by univariate comparisons, variables considered clinically relevant (such as recurrent angina, reinfarction, heart failure, or previous coronary angioplasty or surgery), and the trichotomized variable for the availability of coronary catheterization was forced into the model in the final step. We developed a similar logistic model predicting the use of revascularization.
Results
All 855 hospitals responded to the survey. Thirty-day follow-up was available for 15 060 patients (99·9% enrolled), 6-month outcomes for 14 815 patients (98·3% †Urban=hospital serving a population of more than 100 000 persons in the immediate area or a referral hospital.
‡Teaching=hospital where medical students, residents or cardiology fellows participated in the routine care of patients. §Cardiologist=hospitals in which the care of most patients with myocardial infarction is by staff cardiologists or cardiology fellows. ¶Mean primary PCI rate=% patients that undergo primary percutaneous coronary intervention on average in hospitals in the prior year in routine care (excluding clinical trials). PCI=percutaneous coronary intervention. CABG=coronary artery bypass grafting. CT scan=computerized tomography scanning of the brain. enrolled), and 1-year mortality for 9297 patients (61·7% enrolled). A total of 5662 (37·6%) patients underwent coronary angiography during the index hospitalization. The primary end-point of the trial (30-day all-cause mortality) was equivalent for alteplase and lanoteplase (6·61% vs 6·75%, P=0·045 for equivalence) [25] , thus the current analysis combines the results across fibrinolytic agents stratified by hospital availability of on-site facilities.
Characteristics of the hospitals
Thirty one percent of hospitals had catheterization facilities available on-site 24 h a day, 25% of hospitals had day-only facilities, and 44% of hospitals had no on-site catheterization facilities. Participating hospitals with 24-h facilities tended to be urban, large (>700 beds), teaching centres, with the care for patients with myocardial infarction usually conducted by cardiologists (Table 1) . On-site percutaneous coronary intervention and CABG were available in 95% and 74%, respectively, of hospitals with 24-h facilities, compared to 57% and 28% for hospitals with day-only facilities (P<0·0001 for both).
Baseline patient clinical characteristics
Small but statistically significant differences were found for many baseline characteristics (Table 2) . Patients enrolled in hospitals with 24-h facilities tended to have a lower risk profile, as they were, on average, slightly younger, less likely to be female, and had a lower incidence of Killip class dII chronic heart failure, antecedent angina or anterior myocardial infarction. These patients were also more likely to have undergone coronary revascularization prior to the qualifying acute myocardial infarction.
Baseline characteristics among the 5662 patients selected for angiography during hospitalization were similar for the three groups (Table 3) . Only minor differences were found in the rates of prior CABG, infarct location and time to treatment.
Use of medications
Before the index infarction, use of medications was similar among the three groups. During hospitalization, no differences were found for the in-hospital use of aspirin, oral beta-blockers, angiotensin converting enzyme inhibitors, or hypolipidaemic drugs. In-hospital use of intravenous beta-blockers (22·5%, 18·0%, 19·2%, P=0·0003), nitrates (78·3%, 73·8%, 58·2%, P<0·0001), and glycoprotein IIb/IIIa inhibitors (5·6%, 3·0%, 2·0%, P<0·0001) was slightly more common in hospitals with 24-h facilities, whereas use of diuretics was more common in hospitals with day-only and no on-site facilities (26·7%, 29·8%, 31·1%, P<0·0001).
Use of cardiac procedures
The rates of cardiac angiography, percutaneous coronary intervention, coronary artery bypass grafting, and revascularization were higher in those hospitals with 
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greater access to on-site catheterization facilities (Table  4) . By discharge, the rates of cardiac angiography among patients admitted to hospitals with 24-h facilities was 57·2%, compared to 38·2% and 26·2% for hospitals with day-only and no on-site facilities, respectively (P<0·0001). The corresponding rates of percutaneous coronary intervention were 31·8%, 17·1% and 14·5% (P<0·0001). The rate of any revascularization at 30 days among patients treated in hospitals with 24-h facilities was twice that among patients treated in hospitals without on-site facilities (40·0% vs 19·8%, P<0·0001). If coronary angiography was performed, the likelihood of having a revascularization procedure (either CABG or percutaneous coronary intervention) was similar between patients treated in hospitals with and without 24-h facilities ( Table 4) . The rates of cardiac angiography during the index hospitalization after recurrent angina, reinfarction, 
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heart failure, and cardiogenic shock -major indications for angiography in published guidelines [13, 14] were higher in those hospitals with greater availability of on-site catheterization facilities (Fig. 1) . Relatively low rates of angiography following cardiogenic shock (27-48%) and mechanical complications (10-32%) may have been related to high early mortality.
After adjustment for baseline characteristics, the odds of undergoing coronary angiography were more than double for the patients enrolled in hospitals with 24-h facilities compared to those admitted to hospitals with day-only facilities (odds ratio 2·17, 95% CI 2·0-2·38), and more than four times greater than among those admitted to hospitals without on-site facilities (odds ratio 4·17, 95% CI 3·85-4·54) (Fig. 2) . The presence of 24-h facilities in the hospital was more strongly associated with the likelihood of undergoing angiography than were more common clinical indications -recurrent angina, reinfarction, new or worsening heart failure, or previous coronary intervention or surgery. Among all hospitals participating in the InTIME-II study, coronary angiography was less likely to be performed in older patients (odds ratio 0·48; 95% CI 0·42-0·55), patients with Killip class dII at baseline (odds ratio 0·63; 95% CI 0·55-0·71), patients presenting late (>3 h) (odds ratio 0·79; 95% CI 0·73-0·85), women (odds ratio 0·83; 95% CI 0·76-0·92), and in patients with a history of previous angina (odds ratio 0·69; 95% CI 0·62-0·77), heart failure (odds ratio 0·55; 95% CI 0·42-0·73) or myocardial infarction (odds ratio 0·82; 95% CI 0·72-0·93). Predictors of in-hospital revascularization in the multivariate model were similar (Fig. 3) . 
Clinical outcomes
There were no statistically significant differences in mortality, death or myocardial reinfarction, death or disabling stroke, all stroke, intracranial haemorrhage, or cardiogenic shock at 30 days when hospitals were stratified by the availability of on-site catheterization ( Table 5 ). The adjusted odds ratios for 30-day mortality were 0·94 (95% CI 0·77-1·15) and 0·98 (95% CI 0·82-1·18) for hospitals with day-only and no facilities, respectively, compared to the referent group of hospitals with 24-h facilities. Even among relatively high-risk patients (TIMI Risk Score >4) there was no reduction in mortality associated with 24-h facilities (Fig. 4) . The rates of 30-day recurrent angina were lower in those patients enrolled in hospitals with 24-h (14·7%) or day-only (13·4%) facilities compared to patients enrolled in hospitals with no facilities (16·6%) (P=0·001). Rates of major bleeding (including intracranial haemorrhage) were slightly, albeit significantly higher in those patients enrolled in hospitals with 24-h or day-only facilities compared to patients enrolled in hospitals with no facilities (1·8%, 1·6%, 1·2%, P=0·01), reflecting the higher frequency of catheterization.
All-cause mortality at 1 year was not statistically different among the three groups (9·5%, 10·1%, and 10·5%, P=0·09). The adjusted odds ratios for 1-year mortality were 0·94 (95% CI 0·80-1·09) and 0·95 (95% CI 0·83-1·10) for hospitals with day-only and no catheterization facilities respectively compared to the referent group of hospitals with 24-h availability.
Discussion
This study demonstrated a wide variation in the use of angiography and revascularization with no important differences in outcomes among hospitals stratified by the 
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on-site availability of catheterization. The higher rates of use of cardiac procedures at hospitals with 24-h facilities were not associated with better survival rates at any timepoint through 1-year follow-up, despite a trend to enrol lower risk patients. Among secondary outcomes, only minor reductions in the presence and severity of angina at 30 days were evident in hospitals with 24-h facilities; however, this was offset by an increase in major haemorrhage. The combined use of fibrinolysis and routine revascularization has been studied for more than a decade, and several large clinical trials have failed to show a mortality reduction with this approach [8] [9] [10] . The wide differences in the rate of invasive procedures by on-site catheterization availability with similar outcomes shown in our study, suggest that a more conservative approach may be as effective as a strategy of more frequent catheterization. Our findings are consistent with the results of several studies that have compared mortality rates in patients with acute myocardial infarction in regions or countries with different use of procedures [23, 26, [28] [29] [30] [31] [32] [33] [34] , and with previous reports showing equally good outcomes for patients with acute myocardial infarction cared for at community hospitals vs tertiary care hospitals [16, 21, 24] . However, the 1-year follow-up period may be too short to detect mortality benefits from revascularization, particularly from coronary-artery bypass grafting [34] [35] [36] . In addition, in our study the severity of angina at 30 days was slightly reduced by the higher rates of revascularization.
The observed excess in major bleeding among patients admitted to hospitals with catheterization facilities may be due to the more frequent use of invasive procedures and glycoprotein IIb/IIIa inhibitors. This finding suggests that there may be a cost in terms of periprocedural complications with the use of a more invasive strategy. Recently, similar results were reported in patients with unstable angina or myocardial infarction without ST elevation in the Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry [23] .
In the InTIME-II study, after adjusting for clinical differences, we found that the availability of 24-h on-site cardiac catheterization was the primary predictor of the use of coronary angiography (Fig. 2) . Although greater access to technology and economic incentives may contribute to this pattern of care, physicians who practice in hospitals with availability of coronary procedures actually perceive coronary angiography as more beneficial than do other physicians, particularly for patients with uncomplicated conditions [37] . Reinfarction and recurrent angina were also important predictors of the use of angiography and revascularization in our study. Invasive treatment after recurrent or inducible ischaemia results in a reduction in the incidence of reinfarction, fewer admissions due to unstable angina, and lower prevalence of stable angina in patients with recent acute myocardial infarction [11] . The emergence of recurrent angina as a critical factor for the use of angiography and revascularization in this study is reassuring. However, the overall rates of cardiac 
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angiography after recurrent angina was only 46% in hospitals without on-site angiography compared to 79% and 60% in hospitals with 24-h and day-only facilities, respectively (Fig. 1) . These findings reinforce the need to develop better systems to ensure that patients with post-myocardial infarction ischaemia have more rapid access to angiography, particularly in hospitals without on-site facilities.
In our study, we found that younger age was a major determinant of the use of coronary angiography and revascularization in all three groups of hospitals. Coronary angiography was performed much less frequently in older patients despite the direct relationship between advanced age and the presence of multivessel disease [19, 34] , and the observation that older age was the most important baseline independent predictor of 30-day mortality in the GUSTO-I trial [38] . However, it should be noted that the elderly have an increased risk with cardiac procedures, tend to be more risk averse, and cardiac procedures in elderly patients with acute myocardial infarction have not been shown to improve long-term survival [33] .
Patients with left ventricular dysfunction derive more benefit from revascularization than do those with normal function [35, 36] . In InTIME-II, however, patients with new or worsening chronic heart failure and previous myocardial infarction, were less likely to undergo angiography and revascularization. Rates of cardiac angiography after cardiogenic shock by availability of cardiac catheterization ranged from 27 to 48% (Fig. 1 ). Most patients with cardiogenic shock do not undergo angiography and revascularization due to early deaths, the lack of facilities at the hospitals where they present, or because of doubt as to its efficacy [39, 40] . The recently reported Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial [12] suggested a significant survival benefit at 6 months in patients with shock who received prompt revascularization, although these results were not available until after the completion of InTIME-II.
Conclusions
We demonstrated a marked variation in procedures by availability of catheterization, with only modest differences in outcomes in patients enrolled in a worldwide trial of fibrinolysis. Availability of on-site cardiac catheterization 24 h a day was the major determinant of use of cardiac angiography. Younger age, reinfarction, recurrent angina, and prior percutaneous coronary intervention were also strongly associated with a higher usage of angiography and revascularization. Since angiography and revascularization following fibrinolysis is beneficial to some patients, and neutral or potentially harmful to others, there is a need for additional welldesigned prospective randomized trials, in the current era of potent platelet inhibitors and improved interventional techniques, to address both the appropriate selection of patients and timing for invasive procedures in the ST-elevation myocardial infarction.
The InTIME-II study was supported by Bristol-Myers Squibb.
